Breastfeeding With Type 1 Diabetes: What Research Shows About Insulin in Breastmilk

Mothers with type 1 diabetes who use insulin can safely breastfeed. New research clarifies how insulin moves into breastmilk and what this means for infant health.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

nutritiondietcarbohydratesglycemic

Key takeaways

Insulin is a natural component of breastmilk and is safe for infants, even biosynthetic insulins like aspart, glargine, and lispro
Breastfed infants may have a lower risk of developing type 1 diabetes, though more research is needed
Postpartum insulin needs drop significantly after delivery—typically 30–50% lower than pre-pregnancy doses in the first days
Insulin requirements remain lower during breastfeeding than before pregnancy, but vary widely between individuals

Insulin in Breastmilk Is Safe

Mothers with type 1 diabetes who take insulin can breastfeed safely. Research shows that insulin—including newer biosynthetic forms like aspart, deglutec, detemir, and glargine—passes into breastmilk but poses no harm to nursing infants. Insulin is naturally present in human breastmilk and is broken down safely by the infant's digestive system.

Potential Protective Effect Against Type 1 Diabetes

Emerging evidence suggests that breastmilk insulin may help protect infants from developing type 1 diabetes later in life. While research in this area is still developing, the presence of insulin in breastmilk appears to be beneficial rather than harmful. Mothers with type 2 diabetes who manage blood sugar through diet alone have lower insulin levels in their breastmilk than those taking insulin, but all breastmilk contains some insulin naturally.

What Happens to Insulin Needs After Delivery

Women with type 1 diabetes experience a significant drop in insulin requirements immediately after giving birth. In the first days postpartum, insulin needs typically fall to 30–50% of pre-pregnancy levels. This steep decline happens whether or not a mother breastfeeds.

During the weeks that follow, insulin requirements gradually increase but remain lower than before pregnancy—averaging about 21% below pre-pregnancy doses during breastfeeding. However, there is wide variation between individuals. Some mothers see insulin needs return to pre-pregnancy levels within the first week, while others experience sustained reductions throughout breastfeeding. Close monitoring with your healthcare team is essential to adjust insulin safely during this transition.

Evidence label

Source: Clinical case reports. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.